Header
Header
Article

Senate Democrats vet a tweaked version of drug-pricing bill



And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, since we are pondering what to do with an extended break on this side of the pond. However, we do hope to promenade extensively with the official mascot, hold a listening party or two with Mrs. Pharmalot, and take lots of naps. And how about you? The great outdoors is beckoning, which means you can take a ride in the country, paddle about a lake, or jump in an ocean. You could fire up the grill and invite some friends (but hide the ketchup if the talk turns to current events), or simply reach out to someone special. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

Senate Democrats are vetting a new, tweaked version of a prescription drug-pricing package as they hurtle toward a September deadline to pass any major reforms, according to STAT. It remains uncertain that Congress will pass prescription drug-pricing reform as part of a broader domestic policy package being hammered out between Senate Majority Leader Chuck Schumer and moderate Sen. Joe Manchin (D-W.V.), but this week, the chances are looking better than ever. Negotiations have come a long way, and a drug-pricing policy is now the most solid plank of a potential deal that both Schumer and Manchin agree on.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED





Source link

Back to top button